Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $3.37M | 8,209,725 | 5.27% | 94.73% | Net Selling | |||
| FBLG | FIBROBIOLOGICS INC | $13.79M | 51,456,077 | 8.59% | 12.05% | Net Buying | Net Buying | ||
| PSTV | PLUS THERAPEUTICS INC | $38.48M | 137,429,055 | 8.41% | 17.39% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $52.96M | 28,097,627 | 9.51% | 90.49% | ||||
| NAKA | NAKAMOTO INC | $100.73M | 439,850,889 | 30.04% | 6.81% | Net Buying | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $2.82M | 839,662 | 27.37% | 72.63% | Net Selling | Net Selling | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $459.94M | 108,222,228 | 48.96% | 51.04% | Net Selling | Net Selling | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $26.46M | 115,058,619 | 9.69% | 9.28% | ||||
| OSTX | OS THERAPIES INC | $45.78M | 35,214,352 | 5.04% | 18.78% | Net Selling | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $32.28M | 48,980,307 | 16.09% | 24.13% | Net Buying | |||
| TLRY | TILRAY BRANDS INC | $922.73M | 116,506,916 | 9.63% | 17.71% | Net Buying | Net Buying | ||
| ACET | ADICET BIO INC | $70.50M | 9,578,474 | 29.18% | 70.82% | Net Buying | Net Selling | ||
| SGMO | SANGAMO THERAPEUTICS INC | $158.83M | 336,494,489 | 18.50% | 9.48% | Net Selling | Net Selling | ||
| VNRX | VOLITIONRX LTD | $23.82M | 122,801,572 | 13.15% | 31.35% | Net Buying | Net Selling | ||
| IFRX | INFLARX NV | $59.75M | 67,747,130 | 28.59% | 0.00% | ||||
| ENLV | ENLIVEX LTD | $27.94M | 24,292,833 | 5.44% | 59.15% | ||||
| GUTS | FRACTYL HEALTH INC | $66.33M | 137,044,440 | 79.45% | 20.55% | Net Buying | Net Buying | ||
| SNTI | SENTI BIOSCIENCES INC | $24.45M | 26,290,838 | 17.94% | 82.06% | Net Buying | |||
| TVRD | TVARDI THERAPEUTICS INC | $35.09M | 9,381,344 | 8.39% | 91.61% | Net Selling | |||
| HUMA | HUMACYTE INC | $209.74M | 187,271,321 | 29.50% | 16.42% | Net Selling | |||
| ACRV | ACRIVON THERAPEUTICS INC | $47.33M | 31,555,126 | 55.67% | 44.33% | Net Selling | Net Buying | ||
| TNYA | TENAYA THERAPEUTICS INC | $101.90M | 166,505,885 | 41.14% | 49.74% | Net Buying | Net Selling | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $32.13M | 48,540,200 | 25.50% | 74.50% | Net Selling | Net Selling | ||
| PALI | PALISADE BIO INC | $266.72M | 149,003,210 | 90.97% | 5.57% | Net Buying | Net Buying | ||
| INTZ | INTRUSION INC | $18.07M | 20,102,939 | 8.04% | 75.71% | Net Buying | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $159.18M | 121,511,580 | 36.87% | 33.62% | Net Selling | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $63.33M | 795,658,504 | 7.79% | 4.18% | ||||
| CTSO | CYTOSORBENTS CORP | $43.33M | 62,804,305 | 26.68% | 45.21% | Net Buying | |||
| HOVR | NEW HORIZON AIRCRAFT LTD | $84.08M | 44,252,749 | 2.82% | 20.61% | Net Selling | |||
| CAN | CANAAN INC | $331.63M | 9,939,193,337 | 1.62% | 0.00% | ||||
| CABA | CABALETTA BIO INC | $316.71M | 96,265,204 | 79.20% | 4.52% | Net Buying | Net Buying | ||
| APRE | APREA THERAPEUTICS INC | $5.05M | 6,310,673 | 2.77% | 97.23% | Net Buying | Net Buying | ||
| HELP | CYBIN INC | $367.72M | 49,894,131 | 60.30% | 0.00% | ||||
| DEFT | DEFI TECHNOLOGIES INC | $246.00M | 384,375,991 | 11.79% | 0.00% | ||||
| TCRX | TSCAN THERAPEUTICS INC | $59.59M | 56,747,993 | 54.04% | 30.00% | Net Buying | Net Buying | ||
| BIOX | BIOCERES CROP SOLUTIONS CORP | $36.04M | 63,228,239 | 21.65% | 0.00% | ||||
| DARE | DARE BIOSCIENCE INC | $23.72M | 14,289,229 | 3.71% | 96.29% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.